HCMS Group, Paso Robles, Calif., USA.
J Occup Environ Med. 2009 Dec;51(12):1384-93. doi: 10.1097/JOM.0b013e3181bb808b.
To calculate the fibromyalgia (FM) burden of illness (BOI) from the employer perspective and to compare annual prevalence, work output, absence, and health benefit costs of employees with FM versus osteoarthritis (OA).
Retrospective regression model analysis comparing objective work output, total health benefit (health care, prescription drug, sick leave, disability, workers' compensation) costs, and absence days for FM, versus OA and NoFM cohorts, while controlling for differences in patient characteristics.
FM prevalence was 0.73%; OA 0.90%. Total health benefit costs for FM were $8452 versus $11,253 (P < 0.0001) for OA and $4013 (P < 0.0001) for NoFM, with BOI = $4439. Total absence days were 16.8 versus 19.8 (P < 0.0001) and 6.4 (P < 0.0001), respectively. FM had significantly lower annual work output than NoFM (19.5%, P = 0.003) but comparable with OA.
FM places a significant cost, absence, and productivity burden on employers.
从雇主角度计算纤维肌痛(FM)疾病负担,并比较纤维肌痛与骨关节炎(OA)患者的年度患病率、工作产出、缺勤和健康福利成本。
回顾性回归模型分析比较了 FM、OA 和非 FM 队列的客观工作产出、总健康福利(医疗保健、处方药物、病假、残疾、工人赔偿)成本和缺勤天数,同时控制了患者特征的差异。
FM 的患病率为 0.73%;OA 为 0.90%。FM 的总健康福利成本为 8452 美元,而 OA 和非 FM 分别为 11253 美元(P<0.0001)和 4013 美元(P<0.0001),疾病负担为 4439 美元。总缺勤天数分别为 16.8 天、19.8 天(P<0.0001)和 6.4 天(P<0.0001)。FM 的年工作产出明显低于非 FM(19.5%,P=0.003),但与 OA 相当。
FM 给雇主带来了巨大的成本、缺勤和生产力负担。